These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7658802)

  • 1. Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine.
    Costagliola D; Mary-Krause M
    Lancet; 1995 Aug; 346(8974):578. PubMed ID: 7658802
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
    Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN
    AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.
    Glesby MJ; Hoover DR; Weng S; Graham NM; Phair JP; Detels R; Ho M; Saah AJ
    J Infect Dis; 1996 Jun; 173(6):1477-80. PubMed ID: 8648224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of opportunistic diseases on survival in HIV-infected patients in France, 1992-1997. Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine.
    Lièvre L; Meyohas MC; Costagliola D
    AIDS; 1999 Sep; 13(13):1789-90. PubMed ID: 10509587
    [No Abstract]   [Full Text] [Related]  

  • 5. Some antivirals may lower Kaposi's sarcoma risk.
    Larkin M
    Lancet; 1996 Sep; 348(9030):812. PubMed ID: 8813992
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS-associated Kaposi's sarcoma.
    Jones JL; Hanson DL; Chu SY; Ward JW; Jaffe HW
    Science; 1995 Feb; 267(5201):1078-9. PubMed ID: 7855583
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term nonprogression in HIV infection. Clinical Epidemiology Group from the Centre d'Information et de Soins de l'Immunodéficience Humaine.
    Salhi Y; Costagliola D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(5):409-11. PubMed ID: 9420324
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpesvirus treatment for KS.
    Treat Rev; 1995 Nov; (no 20):5. PubMed ID: 11363024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome.
    Löw P; Neipel F; Rascu A; Steininger H; Manger B; Fleckenstein B; Kalden JR; Harrer T
    Eur J Med Res; 1998 Oct; 3(10):461-4. PubMed ID: 9753702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foscarnet and AIDS-associated Kaposi's sarcoma.
    Cordero E; López-Cortés LF; Viciana P; Alarcón A; Pachón J
    AIDS; 1997 Nov; 11(14):1787-8. PubMed ID: 9386820
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of varicella zoster virus retinitis in AIDS.
    Moorthy RS; Weinberg DV; Teich SA; Berger BB; Minturn JT; Kumar S; Rao NA; Fowell SM; Loose IA; Jampol LM
    Br J Ophthalmol; 1997 Mar; 81(3):189-94. PubMed ID: 9135381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Stebbing J; Sanitt A; Nelson M; Powles T; Gazzard B; Bower M
    Lancet; 2006 May; 367(9521):1495-502. PubMed ID: 16679162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA; Rutledge BK; Morley MG; Duker JS
    Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes cancer?
    Treat Rev; 1995; (no 17):3. PubMed ID: 11362297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic infections in Vancouver.
    Marco M
    GMHC Treat Issues; 1996 Sep; 10(9):4-6. PubMed ID: 11363841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral lesions of the mouth in HIV-infected patients.
    Itin PH; Lautenschlager S
    Dermatology; 1997; 194(1):1-7. PubMed ID: 9031782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
    Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
    AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
    [No Abstract]   [Full Text] [Related]  

  • 18. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
    AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.
    Martin DF; Kuppermann BD; Wolitz RA; Palestine AG; Li H; Robinson CA
    N Engl J Med; 1999 Apr; 340(14):1063-70. PubMed ID: 10194235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus retinitis: new developments in prophylaxis and therapy.
    Jacobson MA
    AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.